BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38057506)

  • 1. SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer.
    Chen HD; Ye Z; Hu HF; Fan GX; Hu YH; Li Z; Li BR; Ji SR; Zhou CJ; Xu XW; Yu XJ; Qin Y
    Acta Pharmacol Sin; 2024 Apr; 45(4):844-856. PubMed ID: 38057506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
    Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
    Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies.
    Hasselluhn MC; Schlösser D; Versemann L; Schmidt GE; Ulisse M; Oschwald J; Zhang Z; Hamdan F; Xiao H; Kopp W; Spitalieri J; Kellner C; Schneider C; Reutlinger K; Nagarajan S; Steuber B; Sastra SA; Palermo CF; Appelhans J; Bohnenberger H; Todorovic J; Kostyuchek I; Ströbel P; Bockelmann A; König A; Ammer-Herrmenau C; Schmidleitner L; Kaulfuß S; Wollnik B; Hahn SA; Neesse A; Singh SK; Bastians H; Reichert M; Sax U; Olive KP; Johnsen SA; Schneider G; Ellenrieder V; Hessmann E
    Gastroenterology; 2024 Feb; 166(2):298-312.e14. PubMed ID: 37913894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation in pancreatic ductal adenocarcinoma.
    Matsumura K; Hayashi H; Uemura N; Ogata Y; Zhao L; Sato H; Shiraishi Y; Kuroki H; Kitamura F; Kaida T; Higashi T; Nakagawa S; Mima K; Imai K; Yamashita YI; Baba H
    Transl Oncol; 2022 Dec; 26():101533. PubMed ID: 36115074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway.
    Wang Y; Zhang A; Li Q; Liu C
    J Ethnopharmacol; 2024 May; 326():117872. PubMed ID: 38325667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting the ferroaddiction of pancreatic cancer cells using Fe-doped nanoparticles.
    Lomphithak T; Sae-Fung A; Sprio S; Tampieri A; Jitkaew S; Fadeel B
    Nanomedicine; 2024 Jan; 55():102714. PubMed ID: 38738528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A2 induces epithelial-mesenchymal transition and metastasis in pancreatic cancer by coordinating transforming growth factor β signaling in SMAD4-dependent manner.
    Chen Q; Guo H; Jiang H; Hu Z; Yang X; Yuan Z; Gao Y; Zhang G; Bai Y
    Cell Death Discov; 2023 Sep; 9(1):356. PubMed ID: 37758734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
    Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
    Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
    Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
    Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
    Bardeesy N; Cheng KH; Berger JH; Chu GC; Pahler J; Olson P; Hezel AF; Horner J; Lauwers GY; Hanahan D; DePinho RA
    Genes Dev; 2006 Nov; 20(22):3130-46. PubMed ID: 17114584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent Inhibition of ERK Activation.
    Ungefroren H; Konukiewitz B; Braun R; Wellner UF; Lehnert H; Marquardt JU
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
    Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
    PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells.
    Zhu S; Zhang Q; Sun X; Zeh HJ; Lotze MT; Kang R; Tang D
    Cancer Res; 2017 Apr; 77(8):2064-2077. PubMed ID: 28130223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
    Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
    BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metastasis suppressor CD82/KAI1 represses the TGF-β
    Lee MS; Lee J; Kim YM; Lee H
    Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradation.
    Su D; Ding C; Wang R; Qiu J; Liu Y; Tao J; Luo W; Weng G; Yang G; Zhang T
    Free Radic Biol Med; 2024 Aug; 221():136-154. PubMed ID: 38763208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4.
    Bertrand-Chapel A; Caligaris C; Fenouil T; Savary C; Aires S; Martel S; Huchedé P; Chassot C; Chauvet V; Cardot-Ruffino V; Morel AP; Subtil F; Mohkam K; Mabrut JY; Tonon L; Viari A; Cassier P; Hervieu V; Castets M; Mauviel A; Sentis S; Bartholin L
    Commun Biol; 2022 Oct; 5(1):1068. PubMed ID: 36207615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Peroxidation, GSH Depletion, and
    Sun L; Dong H; Zhang W; Wang N; Ni N; Bai X; Liu N
    DNA Cell Biol; 2021 Feb; 40(2):172-183. PubMed ID: 33351681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal adenocarcinoma by targeting SMAD4.
    Li Z; Ma Z; Wang S; Yan Q; Zhuang H; Zhou Z; Liu C; Chen Y; Han M; Wu Z; Huang S; Zhou Q; Hou B; Zhang C
    Biol Direct; 2024 Mar; 19(1):24. PubMed ID: 38504385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
    Yasutome M; Gunn J; Korc M
    Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.